Stephen John Wort (S John Wort, Stephen J Wort)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Cardiac Resynchronization Therapy

Interstitial Lung Disease

Polycyclic Aromatic Hydrocarbons

Pulmonary Hypertension

Top Venues

Nature communications

Pulmonary circulation

Respirology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Lucilla Piccari, Stephen John Wort
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before? Thorax (2024)
Oksana A Shlobin, Shelley Shapiro, Stephen John Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 14 (1) (2024)
Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Oksana A Shlobin, Shelley Shapiro, Stephen John Wort, Lucilla Piccari, John A Scandurra, Paul M Hassoun, Sylvia M Nikkho, Steven D Nathan
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension. Pulmonary circulation 14 (1) (2024)
Lucilla Piccari, Stephen John Wort
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before? Thorax 79 (4) (2024)
Lucilla Piccari, Stephen John Wort
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before? Thorax 79 (4) (2024)
Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen, Karl-Heinz Herzig, J Gerry Coghlan, James Lordan, Colin Church, Luke S G Howard, Joanna Pepke-Zaba, Mark Toshner, Stephen John Wort, David G Kiely, Robin Condliffe, Allan Lawrie, Stefan Gräf, Nicholas W Morrell, Martin R Wilkins, Inga Prokopenko, Christopher J Rhodes
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature communications 15 (1) (2024)
Timothy J W Dawes, Colm McCabe, Konstantinos Dimopoulos, Iain D Stewart, Simon Bax, Carl Harries, Chinthaka Bhagya Samaranayake, Aleksander Kempny, Philip L Molyneaux, Samuel Seitler, Thomas Semple, Wei Li, Peter M George, Vasileios Kouranos, Felix Chua, Elizabetta A Renzoni, Maria Kokosi, R Gisli Jenkins, Athol U Wells, Stephen John Wort, Laura C Price
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study. Respirology (Carlton, Vic.) (2022)
Andrew Constantine, Konstantinos Dimopoulos, Petra Jenkins, Robert Michael Tulloh, Robin Condliffe, Katrijn Jansen, Natali A Y Chung, James Oliver, Helen Parry, Samantha Fitzsimmons, Niki Walker, Stephen John Wort, Vasilios Papaioannou, Kate von Klemperer, Paul Clift, null null
Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom. Journal of the American Heart Association 11 (1) (2021)
Brijesh V Patel, Deepa R J Arachchillage, Carole A Ridge, Paolo Bianchi, James F Doyle, Benjamin Garfield, Stephane Ledot, Cliff Morgan, Maurizio Passariello, Susanna Price, Suveer Singh, Louit Thakuria, Sarah Trenfield, Richard Trimlett, Christine Weaver, Stephen John Wort, Tina Xu, Simon P G Padley, Anand Devaraj, Sujal R Desai
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations. American journal of respiratory and critical care medicine 202 (5) (2020)